Cutaquig (immunoglobulin g) NDC 68982-810

Product information

Brand name (proprietary)

Cutaquig

Generic name (nonproprietary)

immunoglobulin g

Active ingredients

Human immunoglobulin g — 165 mg/mL

Dosage form

Solution

Route

Subcutaneous

Labeler

Octapharma USA Inc

Product type

Plasma derivative

Marketing category

BLA — Biologics License ApplicationApplication BLA 125668

Marketing start

May 3, 2019

Listing expires

Dec 31, 2026

Other FDA classes

Antigen Neutralization (Mechanism)Immunoglobulins (Chemical structure)Passively Acquired Immunity (Physiologic effect)

Identifiers

Product ID 68982-810_92279fbb-b633-80a9-0e99-5883db7ca60bSPL ID 92279fbb-b633-80a9-0e99-5883db7ca60b

Pharmacologic class

Human Immunoglobulin G

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468982081001 followed by a unit qualifier and the quantity Copy

Package 68982-0810-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125668

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.